Paricalcitol alleviates intestinal ischemia-reperfusion injury via inhibition of the ATF4-CHOP pathway
These findings suggest that the protective effects of paricalcitol may offer a promising therapeutic strategy for managing intestinal I/R injury.
Authors
- Zhongzhi Jia (ORCID: https://orcid.org/0000-0001-7238-6510)
- Tingting Liu (ORCID: https://orcid.org/0000-0002-7424-5196)
- Jiawei Zhang (ORCID: https://orcid.org/0000-0003-4253-9015)
- Tongqing Xue (ORCID: https://orcid.org/0000-0003-0160-4298)
Institutions
- Xuzhou Medical College (CN)
- Dalian Medical University (CN)
- Huaian First People’s Hospital (CN)
- Second People’s Hospital of Huai’an (CN)
- Changzhou No.2 People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.3389/fphar.2025.1529343
- Primary Topic
- Endoplasmic Reticulum Stress and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00